These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12760897)
1. Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease. Urbina JA; Concepcion JL; Montalvetti A; Rodriguez JB; Docampo R Antimicrob Agents Chemother; 2003 Jun; 47(6):2047-50. PubMed ID: 12760897 [TBL] [Abstract][Full Text] [Related]
2. Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation. Chao MN; Storey M; Li C; Rodríguez MG; Di Salvo F; Szajnman SH; Moreno SNJ; Docampo R; Rodriguez JB Bioorg Med Chem; 2017 Dec; 25(24):6435-6449. PubMed ID: 29107437 [TBL] [Abstract][Full Text] [Related]
3. 2-alkylaminoethyl-1,1-bisphosphonic acids are potent inhibitors of the enzymatic activity of Trypanosoma cruzi squalene synthase. Rodrígues-Poveda CA; González-Pacanowska D; Szajnman SH; Rodríguez JB Antimicrob Agents Chemother; 2012 Aug; 56(8):4483-6. PubMed ID: 22585217 [TBL] [Abstract][Full Text] [Related]
4. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Garzoni LR; Caldera A; Meirelles Mde N; de Castro SL; Docampo R; Meints GA; Oldfield E; Urbina JA Int J Antimicrob Agents; 2004 Mar; 23(3):273-85. PubMed ID: 15164969 [TBL] [Abstract][Full Text] [Related]
5. WC-9 a Lead Drug with Great Prospects for American Trypanosomiasis and Toxoplasmosis. Rodriguez JB Mini Rev Med Chem; 2016; 16(15):1195-1200. PubMed ID: 27290911 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi. Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents. Elicio PD; Chao MN; Galizzi M; Li C; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB Eur J Med Chem; 2013 Nov; 69():480-9. PubMed ID: 24090919 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi. Elhalem E; Bailey BN; Docampo R; Ujváry I; Szajnman SH; Rodriguez JB J Med Chem; 2002 Aug; 45(18):3984-99. PubMed ID: 12190320 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation. Szajnman SH; Yan W; Bailey BN; Docampo R; Elhalem E; Rodriguez JB J Med Chem; 2000 May; 43(9):1826-40. PubMed ID: 10794699 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Urbina JA; Concepcion JL; Caldera A; Payares G; Sanoja C; Otomo T; Hiyoshi H Antimicrob Agents Chemother; 2004 Jul; 48(7):2379-87. PubMed ID: 15215084 [TBL] [Abstract][Full Text] [Related]
11. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972 [TBL] [Abstract][Full Text] [Related]
12. Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii. Chao MN; Matiuzzi CE; Storey M; Li C; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB ChemMedChem; 2015 Jun; 10(6):1094-108. PubMed ID: 25914175 [TBL] [Abstract][Full Text] [Related]
13. Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii. Chao MN; Li C; Storey M; Falcone BN; Szajnman SH; Bonesi SM; Docampo R; Moreno SN; Rodriguez JB ChemMedChem; 2016 Dec; 11(24):2690-2702. PubMed ID: 27886451 [TBL] [Abstract][Full Text] [Related]
15. Squalene synthase as a target for Chagas disease therapeutics. Shang N; Li Q; Ko TP; Chan HC; Li J; Zheng Y; Huang CH; Ren F; Chen CC; Zhu Z; Galizzi M; Li ZH; Rodrigues-Poveda CA; Gonzalez-Pacanowska D; Veiga-Santos P; de Carvalho TM; de Souza W; Urbina JA; Wang AH; Docampo R; Li K; Liu YL; Oldfield E; Guo RT PLoS Pathog; 2014 May; 10(5):e1004114. PubMed ID: 24789335 [TBL] [Abstract][Full Text] [Related]
16. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi. Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472 [TBL] [Abstract][Full Text] [Related]
17. Ergosterol biosynthesis and drug development for Chagas disease. Urbina JA Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():311-8. PubMed ID: 19753490 [TBL] [Abstract][Full Text] [Related]
18. Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi. Chao MN; Lorenzo-Ocampo MV; Szajnman SH; Docampo R; Rodriguez JB Bioorg Med Chem; 2019 Apr; 27(7):1350-1361. PubMed ID: 30808607 [TBL] [Abstract][Full Text] [Related]
19. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Urbina JA; Payares G; Contreras LM; Liendo A; Sanoja C; Molina J; Piras M; Piras R; Perez N; Wincker P; Loebenberg D Antimicrob Agents Chemother; 1998 Jul; 42(7):1771-7. PubMed ID: 9661019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]